Castres, France

Serge Basquin

This inventor holds 2 USPTO granted patents. Top assignee: Pierre Fabre Medicament. Active years: 1988-1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1988-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Serge Basquin

Introduction

Serge Basquin is a notable inventor based in Castres, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative solutions for medical treatments. With a total of 2 patents, his work reflects a commitment to advancing healthcare.

Latest Patents

Among his latest patents is a stable aqueous solution of vincristine sulfate. This invention focuses on providing a reliable formulation for this important compound. Another significant patent is for a method for the treatment of periodontal pockets using a composition that combines collagen with antiseptic and/or anti-inflammatory active principles. This composition is designed for the topical treatment of periodontal complaints, showcasing his dedication to improving dental health.

Career Highlights

Serge Basquin is associated with Pierre Fabre Medicament, a company known for its innovative pharmaceutical products. His work at this institution has allowed him to contribute to the development of effective medical solutions that address various health issues.

Collaborations

Throughout his career, Serge has collaborated with talented individuals such as Genevieve Thomas-Leurquin and Anne Gayot. These partnerships have likely enriched his research and development efforts, leading to successful innovations.

Conclusion

In summary, Serge Basquin is an accomplished inventor whose work in pharmaceuticals has led to valuable patents that enhance medical treatments. His contributions continue to impact the healthcare industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…